Supplemental Figure S9 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
Year: 2026
Type: supplementary-materials
Abstract: Evaluation of the DNA-PK inhibitors plus TOP2 poisons in preclinical models of EWS
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7164993665
Cites:
Cited by:
Related to:
